StockTipsArenaBeta

Strides Pharma Science Share price target & analyst calls

Sector:Pharmaceuticals & Biotechnology
₹998.4-26.90 (-2.62%)
As of 22 Oct 2026

Only one active 1-year target

The long-term call is BUY

₹1,35235.4% above today's price

Strides Pharma Science has one active 1-year share price target: ₹1,352 from Geojit Financial Services (2 Jul 2026). One target is a single view, not a consensus.

1
1 BUY · 0 SELL, all horizons
1
with an active 1Y target
N/A
8 of 10 closed calls needed
9
all horizons, open and closed
Watch STAR for new buy/sell callsGet alertsSee 44 Pharmaceuticals & Biotechnology sector analyst picks

Not investment advice; past performance doesn't guarantee future results. · Public beta — data is auto-extracted and may contain errors.

All tips (9)

BUYTarget₹1,352
GFbyGeojit Financial Services+35.4% to target
1 Year* · 8 mo left · 2 Jul 2026 · entry ₹1,126.4 · via Institutional / Brokerage ResearchP&L -11.4%
BUYTarget₹1,119
GFbyGeojit Financial ServicesTarget hit
1 Year* · 27 Mar 2026 · entry ₹940.3 · via Institutional / Brokerage Researchexit ₹1,119
SELLTarget₹1,175
GFbyGeojit Financial ServicesTarget hit
1 Year* · 27 Aug 2024 · entry ₹1,318.95 · via Institutional / Brokerage Researchexit ₹1,175
BUYTarget₹1,874
SRbySharekhan ResearchExpired
1 Year* · 24 Oct 2024 · entry ₹1,535.1 · via Institutional / Brokerage Researchexit ₹814.55
BUYTarget₹1,200
NJbyNilesh Jain, Centrum BrokingTarget hit
1–3 Months · 7 Sept 2026 · entry ₹1,156 · via NDTV Profitexit ₹1,200
BUYTarget₹1,150
SGbySachin GuptaTarget hit
1–3 Months · 6 May 2026 · entry ₹1,068.5 · via CNBC Awaaz.exit ₹1,150
BUYTarget₹1,278
RBbyRakesh BansalStop-loss hit
1–2 Weeks* · 21 Sept 2026 · entry ₹1,239.5 · via CNBC Awaaz.exit ₹1,223
BUYTarget₹1,250
NCbyNirav Chheda, Nirmal Bang SecuritiesStop-loss hit
1–2 Weeks* · 8 Sept 2026 · entry ₹1,189.6 · via CNBC Awaaz.exit ₹1,160
BUYTarget₹1,150
RSbyRajesh SatputeStop-loss hit
1–2 Weeks · 29 Jun 2026 · entry ₹1,100 · via CNBC Awaaz.exit ₹1,080

* Horizon not stated by the source; assumed from how far the target is from the entry price.

Compare Pharmaceuticals & Biotechnology targets

Most-covered stocks in the sector · average 1-year target

See all Pharmaceuticals & Biotechnology analyst picks